MK-3577

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-3577, covering 2017-01-11 to 2017-01-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety and Efficacy of MK-3577 in Participants With Type 2 Diabetes Mellitus (MK-3577-009) [Phase 2]

See pricing